Endocrine Abstracts

Aim of the study: To test B-Lymphocyte Stimulator (BLyS) as a new serological marker in the follow-up of patients with neuroendocrine tumors (NET).Methods: Eighty-one consecutive patients with NET and 56 age and sex-matched controls were enrolled in the study. According to the clinical course, patients were classified in 2 subgroups: evidence of persistent but stable disease or in remission (n=45) and patients with evidence of recurrent disease (p...